PDCD1 and cancer: The priming therapy (including vaccines, chemotherapy or radiotherapy) enhances T cell response and PD-1 pathway inhibitors remove cancer-meditated suppression, which implies the rationality of combination immune-activating therapy with immunotherapy in cold tumors.